(Q46976616)

27 December 2017

title

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers (English)

1 reference

27 December 2017

Nancy Lockhart

5

0 references

author name string

Chris-Ellyn Johanson

1

1 reference

27 December 2017

Kirk A Frey

2

1 reference

27 December 2017

Leslie H Lundahl

3

1 reference

27 December 2017

Pamela Keenan

4

1 reference

27 December 2017

John Roll

6

1 reference

27 December 2017

Gantt P Galloway

7

1 reference

27 December 2017

Robert A Koeppe

8

1 reference

27 December 2017

Michael R Kilbourn

9

1 reference

27 December 2017

Trevor Robbins

10

1 reference

27 December 2017

Charles R Schuster

11

1 reference

27 December 2017

publication date

3 March 2006

1 reference

27 December 2017

number of pages

12

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

27 December 2017

volume

185

1 reference

27 December 2017

issue

3

1 reference

27 December 2017

page(s)

327-338

1 reference

27 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-006-0330-6

exact match

0 references

cites work

Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0330-6

[3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0330-6

Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0330-6

Cognitive performance of current methamphetamine and cocaine abusers

21 January 2018

1 reference

12 December 2020

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

1 reference

12 December 2020

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments

1 reference

12 December 2020

Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy

1 reference

12 December 2020

Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.

1 reference

12 December 2020

A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated

1 reference

12 December 2020

Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

1 reference

12 December 2020

Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers.

1 reference

12 December 2020

Effects of dopaminergic agents on eye tracking before and after repeated methamphetamine

1 reference

12 December 2020

Dyadic short forms of the Wechsler Adult Intelligence Scale-III.

1 reference

12 December 2020

Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain

1 reference

12 December 2020

Cognitive impairment in individuals currently using methamphetamine

1 reference

12 December 2020

Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals

1 reference

12 December 2020

Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence

1 reference

12 December 2020

Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss

1 reference

12 December 2020

A new PET ligand for the dopamine transporter: studies in the human brain

1 reference

12 December 2020

Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease

1 reference

12 December 2020

Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.

1 reference

12 December 2020

Fluorescence histochemistry indicates damage of striatal dopamine nerve terminals in rats after multiple doses of methamphetamine

1 reference

12 December 2020

Structural abnormalities in the brains of human subjects who use methamphetamine.

1 reference

12 December 2020

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

12 December 2020

Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers.

1 reference

12 December 2020

Analysis of four dopaminergic tracers kinetics using two different tissue input function methods.

1 reference

12 December 2020

Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine

1 reference

12 December 2020

Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys.

1 reference

12 December 2020

Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users

1 reference

12 December 2020

The effects of methamphetamine on fine motor control in rhesus monkeys

1 reference

12 December 2020

Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain

1 reference

12 December 2020

Why is parkinsonism not a feature of human methamphetamine users?

1 reference

12 December 2020

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

12 December 2020

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

1 reference

12 December 2020

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

1 reference

12 December 2020

Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms

1 reference

12 December 2020

10.1007/S00213-006-0330-6

Identifiers

DOI

1 reference

27 December 2017

PubMed ID

16518646

1 reference

27 December 2017